Global PARP Inhibitor Biomarkers Market Size, Share & Trends Analysis Report By Product (Kits, and Assays), By Application, By Services (BRCA 1 & 2 Testing, HRD Testing, HRR Testing, and Others), By Regional Outlook and Forecast, 2024

List of Tables

The Global PARP Inhibitor Biomarkers Market size is expected to reach $1.6 billion by 2031, rising at a market growth of 8.3% CAGR during the forecast period.

North America boasts advanced healthcare infrastructure, including well-established clinical laboratories, oncology centres, and research institutions. Thus, the North America region acquired 42.5% revenue share in the market 2023. The availability of diagnostic technologies and skilled healthcare professionals enhances the accessibility and utilization of biomarker testing services, driving the demand for it in North America.

Oncology research is continually uncovering new biomarkers associated with cancer development, progression, and response to therapy. As our understanding of the molecular pathways underlying cancer improves, researchers are identifying biomarkers that predict response to specific treatments, including it.

Additionally, point-of-care testing brings diagnostic capabilities closer to the patient, enabling biomarker testing to be performed outside traditional laboratory settings, such as outpatient clinics, physician offices, or even the patient's home. Hence, the expansion of point-of-care testing is raising the market's growth.

However, Biomarker testing often involves sophisticated laboratory techniques and specialized equipment, which can be expensive to procure and maintain. Additionally, the cost of reagents, consumables, and personnel required for biomarker testing adds to the overall expense. In conclusion, the high cost of biomarker testing hinders the market's growth.

Economic hardships and changes in healthcare priorities during the pandemic affected patient access to cancer treatments, including this. Financial constraints, job losses, and changes in insurance coverage may have influenced treatment decisions and patient adherence. Thus, the COVID-19 pandemic had a negative impact on the market.

Product Outlook

Based on product, the market is divided into kits and assays. In 2023, the kits segment garnered 63.8% revenue share in the market. Biomarker testing kits offer a user-friendly and convenient solution for healthcare providers to perform biomarker testing in-house without requiring specialized laboratory infrastructure or expertise.

Application Outlook

Based on application, the market is categorized into breast cancer, ovarian cancer, and others. The ovarian cancer segment witnessed 30.7% revenue share in the market in 2023. PARP inhibitors have demonstrated clinical efficacy in treating ovarian cancer patients with BRCA mutations. Clinical trials have shown that PARP inhibitors.

Services Outlook

On the basis of services, the market is segmented into BRCA 1 & 2 testing, HRD testing, HRR testing, and others. The BRCA 1 & 2 testing segment recorded 41.8% revenue share in the market in 2023. BRCA1 and BRCA2 mutations are strongly associated with increased sensitivity to this in certain cancers, particularly breast and ovarian cancer.

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 24.4% revenue share in the market. The Asia Pacific region is experiencing a significant increase in the incidence of cancer, including breast, ovarian, and other cancers associated with PARP inhibitor therapy.

List of Key Companies Profiled

Myriad Genetics, Inc.
Thermo Fisher Scientific, Inc.
Illumina, Inc.
NeoGenomics Laboratories
Qiagen N.V
Agilent Technologies, Inc.
Merck KGaA
Bayer AG
AstraZeneca PLC
GlaxoSmithKline PLC (GSK)

Global PARP Inhibitor Biomarkers Market Report Segmentation

By Product

Kits
Assays

By Application

Breast Cancer
Ovarian Cancer
Others

By Services

BRCA 1 & 2 Testing
HRD Testing
HRR Testing
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1Global PARP Inhibitor Biomarkers Market, by Product
- 1.4.2Global PARP Inhibitor Biomarkers Market, by Application
- 1.4.3Global PARP Inhibitor Biomarkers Market, by Services
- 1.4.4Global PARP Inhibitor Biomarkers Market, by Geography
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter's Five Forces Analysis

Chapter 4.Global PARP Inhibitor Biomarkers Market by Product

4.1Global Kits Market by Region
4.2Global Assays Market by Region

Chapter 5.Global PARP Inhibitor Biomarkers Market by Application

5.1Global Breast Cancer Market by Region
5.2Global Ovarian Cancer Market by Region
5.3Global Others Market by Region

Chapter 6.Global PARP Inhibitor Biomarkers Market by Services

6.1Global BRCA 1 & 2 Testing Market by Region
6.2Global HRD Testing Market by Region
6.3Global HRR Testing Market by Region
6.4Global Others Market by Region

Chapter 7.Global PARP Inhibitor Biomarkers Market by Region

7.1North America PARP Inhibitor Biomarkers Market
- 7.1.1North America PARP Inhibitor Biomarkers Market by Product
  - 7.1.1.1North America Kits Market by Region
  - 7.1.1.2North America Assays Market by Region
- 7.1.2North America PARP Inhibitor Biomarkers Market by Application
  - 7.1.2.1North America Breast Cancer Market by Country
  - 7.1.2.2North America Ovarian Cancer Market by Country
  - 7.1.2.3North America Others Market by Country
- 7.1.3North America PARP Inhibitor Biomarkers Market by Services
  - 7.1.3.1North America BRCA 1 & 2 Testing Market by Country
  - 7.1.3.2North America HRD Testing Market by Country
  - 7.1.3.3North America HRR Testing Market by Country
  - 7.1.3.4North America Others Market by Country
- 7.1.4North America PARP Inhibitor Biomarkers Market by Country
  - 7.1.4.1US PARP Inhibitor Biomarkers Market
    - 7.1.4.1.1US PARP Inhibitor Biomarkers Market by Product
    - 7.1.4.1.2US PARP Inhibitor Biomarkers Market by Application
    - 7.1.4.1.3US PARP Inhibitor Biomarkers Market by Services
  - 7.1.4.2Canada PARP Inhibitor Biomarkers Market
    - 7.1.4.2.1Canada PARP Inhibitor Biomarkers Market by Product
    - 7.1.4.2.2Canada PARP Inhibitor Biomarkers Market by Application
    - 7.1.4.2.3Canada PARP Inhibitor Biomarkers Market by Services
  - 7.1.4.3Mexico PARP Inhibitor Biomarkers Market
    - 7.1.4.3.1Mexico PARP Inhibitor Biomarkers Market by Product
    - 7.1.4.3.2Mexico PARP Inhibitor Biomarkers Market by Application
    - 7.1.4.3.3Mexico PARP Inhibitor Biomarkers Market by Services
  - 7.1.4.4Rest of North America PARP Inhibitor Biomarkers Market
    - 7.1.4.4.1Rest of North America PARP Inhibitor Biomarkers Market by Product
    - 7.1.4.4.2Rest of North America PARP Inhibitor Biomarkers Market by Application
    - 7.1.4.4.3Rest of North America PARP Inhibitor Biomarkers Market by Services
7.2Europe PARP Inhibitor Biomarkers Market
- 7.2.1Europe PARP Inhibitor Biomarkers Market by Product
  - 7.2.1.1Europe Kits Market by Country
  - 7.2.1.2Europe Assays Market by Country
- 7.2.2Europe PARP Inhibitor Biomarkers Market by Application
  - 7.2.2.1Europe Breast Cancer Market by Country
  - 7.2.2.2Europe Ovarian Cancer Market by Country
  - 7.2.2.3Europe Others Market by Country
- 7.2.3Europe PARP Inhibitor Biomarkers Market by Services
  - 7.2.3.1Europe BRCA 1 & 2 Testing Market by Country
  - 7.2.3.2Europe HRD Testing Market by Country
  - 7.2.3.3Europe HRR Testing Market by Country
  - 7.2.3.4Europe Others Market by Country
- 7.2.4Europe PARP Inhibitor Biomarkers Market by Country
  - 7.2.4.1Germany PARP Inhibitor Biomarkers Market
    - 7.2.4.1.1Germany PARP Inhibitor Biomarkers Market by Product
    - 7.2.4.1.2Germany PARP Inhibitor Biomarkers Market by Application
    - 7.2.4.1.3Germany PARP Inhibitor Biomarkers Market by Services
  - 7.2.4.2UK PARP Inhibitor Biomarkers Market
    - 7.2.4.2.1UK PARP Inhibitor Biomarkers Market by Product
    - 7.2.4.2.2UK PARP Inhibitor Biomarkers Market by Application
    - 7.2.4.2.3UK PARP Inhibitor Biomarkers Market by Services
  - 7.2.4.3France PARP Inhibitor Biomarkers Market
    - 7.2.4.3.1France PARP Inhibitor Biomarkers Market by Product
    - 7.2.4.3.2France PARP Inhibitor Biomarkers Market by Application
    - 7.2.4.3.3France PARP Inhibitor Biomarkers Market by Services
  - 7.2.4.4Russia PARP Inhibitor Biomarkers Market
    - 7.2.4.4.1Russia PARP Inhibitor Biomarkers Market by Product
    - 7.2.4.4.2Russia PARP Inhibitor Biomarkers Market by Application
    - 7.2.4.4.3Russia PARP Inhibitor Biomarkers Market by Services
  - 7.2.4.5Spain PARP Inhibitor Biomarkers Market
    - 7.2.4.5.1Spain PARP Inhibitor Biomarkers Market by Product
    - 7.2.4.5.2Spain PARP Inhibitor Biomarkers Market by Application
    - 7.2.4.5.3Spain PARP Inhibitor Biomarkers Market by Services
  - 7.2.4.6Italy PARP Inhibitor Biomarkers Market
    - 7.2.4.6.1Italy PARP Inhibitor Biomarkers Market by Product
    - 7.2.4.6.2Italy PARP Inhibitor Biomarkers Market by Application
    - 7.2.4.6.3Italy PARP Inhibitor Biomarkers Market by Services
  - 7.2.4.7Rest of Europe PARP Inhibitor Biomarkers Market
    - 7.2.4.7.1Rest of Europe PARP Inhibitor Biomarkers Market by Product
    - 7.2.4.7.2Rest of Europe PARP Inhibitor Biomarkers Market by Application
    - 7.2.4.7.3Rest of Europe PARP Inhibitor Biomarkers Market by Services
7.3Asia Pacific PARP Inhibitor Biomarkers Market
- 7.3.1Asia Pacific PARP Inhibitor Biomarkers Market by Product
  - 7.3.1.1Asia Pacific Kits Market by Country
  - 7.3.1.2Asia Pacific Assays Market by Country
- 7.3.2Asia Pacific PARP Inhibitor Biomarkers Market by Application
  - 7.3.2.1Asia Pacific Breast Cancer Market by Country
  - 7.3.2.2Asia Pacific Ovarian Cancer Market by Country
  - 7.3.2.3Asia Pacific Others Market by Country
- 7.3.3Asia Pacific PARP Inhibitor Biomarkers Market by Services
  - 7.3.3.1Asia Pacific BRCA 1 & 2 Testing Market by Country
  - 7.3.3.2Asia Pacific HRD Testing Market by Country
  - 7.3.3.3Asia Pacific HRR Testing Market by Country
  - 7.3.3.4Asia Pacific Others Market by Country
- 7.3.4Asia Pacific PARP Inhibitor Biomarkers Market by Country
  - 7.3.4.1China PARP Inhibitor Biomarkers Market
    - 7.3.4.1.1China PARP Inhibitor Biomarkers Market by Product
    - 7.3.4.1.2China PARP Inhibitor Biomarkers Market by Application
    - 7.3.4.1.3China PARP Inhibitor Biomarkers Market by Services
  - 7.3.4.2Japan PARP Inhibitor Biomarkers Market
    - 7.3.4.2.1Japan PARP Inhibitor Biomarkers Market by Product
    - 7.3.4.2.2Japan PARP Inhibitor Biomarkers Market by Application
    - 7.3.4.2.3Japan PARP Inhibitor Biomarkers Market by Services
  - 7.3.4.3India PARP Inhibitor Biomarkers Market
    - 7.3.4.3.1India PARP Inhibitor Biomarkers Market by Product
    - 7.3.4.3.2India PARP Inhibitor Biomarkers Market by Application
    - 7.3.4.3.3India PARP Inhibitor Biomarkers Market by Services
  - 7.3.4.4South Korea PARP Inhibitor Biomarkers Market
    - 7.3.4.4.1South Korea PARP Inhibitor Biomarkers Market by Product
    - 7.3.4.4.2South Korea PARP Inhibitor Biomarkers Market by Application
    - 7.3.4.4.3South Korea PARP Inhibitor Biomarkers Market by Services
  - 7.3.4.5Singapore PARP Inhibitor Biomarkers Market
    - 7.3.4.5.1Singapore PARP Inhibitor Biomarkers Market by Product
    - 7.3.4.5.2Singapore PARP Inhibitor Biomarkers Market by Application
    - 7.3.4.5.3Singapore PARP Inhibitor Biomarkers Market by Services
  - 7.3.4.6Malaysia PARP Inhibitor Biomarkers Market
    - 7.3.4.6.1Malaysia PARP Inhibitor Biomarkers Market by Product
    - 7.3.4.6.2Malaysia PARP Inhibitor Biomarkers Market by Application
    - 7.3.4.6.3Malaysia PARP Inhibitor Biomarkers Market by Services
  - 7.3.4.7Rest of Asia Pacific PARP Inhibitor Biomarkers Market
    - 7.3.4.7.1Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Product
    - 7.3.4.7.2Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Application
    - 7.3.4.7.3Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Services
7.4LAMEA PARP Inhibitor Biomarkers Market
- 7.4.1LAMEA PARP Inhibitor Biomarkers Market by Product
  - 7.4.1.1LAMEA Kits Market by Country
  - 7.4.1.2LAMEA Assays Market by Country
- 7.4.2LAMEA PARP Inhibitor Biomarkers Market by Application
  - 7.4.2.1LAMEA Breast Cancer Market by Country
  - 7.4.2.2LAMEA Ovarian Cancer Market by Country
  - 7.4.2.3LAMEA Others Market by Country
- 7.4.3LAMEA PARP Inhibitor Biomarkers Market by Services
  - 7.4.3.1LAMEA BRCA 1 & 2 Testing Market by Country
  - 7.4.3.2LAMEA HRD Testing Market by Country
  - 7.4.3.3LAMEA HRR Testing Market by Country
  - 7.4.3.4LAMEA Others Market by Country
- 7.4.4LAMEA PARP Inhibitor Biomarkers Market by Country
  - 7.4.4.1Brazil PARP Inhibitor Biomarkers Market
    - 7.4.4.1.1Brazil PARP Inhibitor Biomarkers Market by Product
    - 7.4.4.1.2Brazil PARP Inhibitor Biomarkers Market by Application
    - 7.4.4.1.3Brazil PARP Inhibitor Biomarkers Market by Services
  - 7.4.4.2Argentina PARP Inhibitor Biomarkers Market
    - 7.4.4.2.1Argentina PARP Inhibitor Biomarkers Market by Product
    - 7.4.4.2.2Argentina PARP Inhibitor Biomarkers Market by Application
    - 7.4.4.2.3Argentina PARP Inhibitor Biomarkers Market by Services
  - 7.4.4.3UAE PARP Inhibitor Biomarkers Market
    - 7.4.4.3.1UAE PARP Inhibitor Biomarkers Market by Product
    - 7.4.4.3.2UAE PARP Inhibitor Biomarkers Market by Application
    - 7.4.4.3.3UAE PARP Inhibitor Biomarkers Market by Services
  - 7.4.4.4Saudi Arabia PARP Inhibitor Biomarkers Market
    - 7.4.4.4.1Saudi Arabia PARP Inhibitor Biomarkers Market by Product
    - 7.4.4.4.2Saudi Arabia PARP Inhibitor Biomarkers Market by Application
    - 7.4.4.4.3Saudi Arabia PARP Inhibitor Biomarkers Market by Services
  - 7.4.4.5South Africa PARP Inhibitor Biomarkers Market
    - 7.4.4.5.1South Africa PARP Inhibitor Biomarkers Market by Product
    - 7.4.4.5.2South Africa PARP Inhibitor Biomarkers Market by Application
    - 7.4.4.5.3South Africa PARP Inhibitor Biomarkers Market by Services
  - 7.4.4.6Nigeria PARP Inhibitor Biomarkers Market
    - 7.4.4.6.1Nigeria PARP Inhibitor Biomarkers Market by Product
    - 7.4.4.6.2Nigeria PARP Inhibitor Biomarkers Market by Application
    - 7.4.4.6.3Nigeria PARP Inhibitor Biomarkers Market by Services
  - 7.4.4.7Rest of LAMEA PARP Inhibitor Biomarkers Market
    - 7.4.4.7.1Rest of LAMEA PARP Inhibitor Biomarkers Market by Product
    - 7.4.4.7.2Rest of LAMEA PARP Inhibitor Biomarkers Market by Application
    - 7.4.4.7.3Rest of LAMEA PARP Inhibitor Biomarkers Market by Services

Chapter 8.Company Profiles

8.1Myriad Genetics, Inc.
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Research & Development Expenses
8.2Thermo Fisher Scientific, Inc.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expenses
- 8.2.5SWOT Analysis
8.3Illumina, Inc.
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Segment and Regional Analysis
- 8.3.4Research & Development Expense
- 8.3.5SWOT Analysis
8.4Neogenomics, Inc.
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Segmental and Regional Analysis
- 8.4.4Research & Development Expenses
8.5Qiagen N.V.
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Regional Analysis
- 8.5.4Research & Development Expense
- 8.5.5SWOT Analysis
8.6Agilent Technologies, Inc.
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Segmental and Regional Analysis
- 8.6.4Research & Development Expense
- 8.6.5SWOT Analysis
8.7Merck KGaA
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expense
- 8.7.5SWOT Analysis
8.8Bayer AG
- 8.8.1Company Overview
- 8.8.2Financial Analysis
- 8.8.3Segmental and Regional Analysis
- 8.8.4Research & Development Expense
- 8.8.5SWOT Analysis
8.9AstraZeneca PLC
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Regional Analysis
- 8.9.4Research & Development Expenses
- 8.9.5SWOT Analysis
8.10.GlaxoSmithKline PLC (GSK)
- 8.10.1Company Overview
- 8.10.2Financial Analysis
- 8.10.3Regional Analysis
- 8.10.4Research & Development Expense
- 8.10.5SWOT Analysis

Chapter 9.Winning Imperatives of PARP Inhibitor Biomarkers Market

LIST OF TABLES

TABLE 1Global PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 2Global PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 3Global PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 4Global PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 5Global Kits Market by Region, 2020 - 2023, USD Million
TABLE 6Global Kits Market by Region, 2024 - 2031, USD Million
TABLE 7Global Assays Market by Region, 2020 - 2023, USD Million
TABLE 8Global Assays Market by Region, 2024 - 2031, USD Million
TABLE 9Global PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 10Global PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 11Global Breast Cancer Market by Region, 2020 - 2023, USD Million
TABLE 12Global Breast Cancer Market by Region, 2024 - 2031, USD Million
TABLE 13Global Ovarian Cancer Market by Region, 2020 - 2023, USD Million
TABLE 14Global Ovarian Cancer Market by Region, 2024 - 2031, USD Million
TABLE 15Global Others Market by Region, 2020 - 2023, USD Million
TABLE 16Global Others Market by Region, 2024 - 2031, USD Million
TABLE 17Global PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 18Global PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 19Global BRCA 1 & 2 Testing Market by Region, 2020 - 2023, USD Million
TABLE 20Global BRCA 1 & 2 Testing Market by Region, 2024 - 2031, USD Million
TABLE 21Global HRD Testing Market by Region, 2020 - 2023, USD Million
TABLE 22Global HRD Testing Market by Region, 2024 - 2031, USD Million
TABLE 23Global HRR Testing Market by Region, 2020 - 2023, USD Million
TABLE 24Global HRR Testing Market by Region, 2024 - 2031, USD Million
TABLE 25Global Others Market by Region, 2020 - 2023, USD Million
TABLE 26Global Others Market by Region, 2024 - 2031, USD Million
TABLE 27Global PARP Inhibitor Biomarkers Market by Region, 2020 - 2023, USD Million
TABLE 28Global PARP Inhibitor Biomarkers Market by Region, 2024 - 2031, USD Million
TABLE 29North America PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 30North America PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 31North America PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 32North America PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 33North America Kits Market by Region, 2020 - 2023, USD Million
TABLE 34North America Kits Market by Region, 2024 - 2031, USD Million
TABLE 35North America Assays Market by Region, 2020 - 2023, USD Million
TABLE 36North America Assays Market by Region, 2024 - 2031, USD Million
TABLE 37North America PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 38North America PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 39North America Breast Cancer Market by Country, 2020 - 2023, USD Million
TABLE 40North America Breast Cancer Market by Country, 2024 - 2031, USD Million
TABLE 41North America Ovarian Cancer Market by Country, 2020 - 2023, USD Million
TABLE 42North America Ovarian Cancer Market by Country, 2024 - 2031, USD Million
TABLE 43North America Others Market by Country, 2020 - 2023, USD Million
TABLE 44North America Others Market by Country, 2024 - 2031, USD Million
TABLE 45North America PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 46North America PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 47North America BRCA 1 & 2 Testing Market by Country, 2020 - 2023, USD Million
TABLE 48North America BRCA 1 & 2 Testing Market by Country, 2024 - 2031, USD Million
TABLE 49North America HRD Testing Market by Country, 2020 - 2023, USD Million
TABLE 50North America HRD Testing Market by Country, 2024 - 2031, USD Million
TABLE 51North America HRR Testing Market by Country, 2020 - 2023, USD Million
TABLE 52North America HRR Testing Market by Country, 2024 - 2031, USD Million
TABLE 53North America Others Market by Country, 2020 - 2023, USD Million
TABLE 54North America Others Market by Country, 2024 - 2031, USD Million
TABLE 55North America PARP Inhibitor Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 56North America PARP Inhibitor Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 57US PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 58US PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 59US PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 60US PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 61US PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 62US PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 63US PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 64US PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 65Canada PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 66Canada PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 67Canada PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 68Canada PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 69Canada PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 70Canada PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 71Canada PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 72Canada PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 73Mexico PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 74Mexico PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 75Mexico PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 76Mexico PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 77Mexico PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 78Mexico PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 79Mexico PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 80Mexico PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 81Rest of North America PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 82Rest of North America PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 83Rest of North America PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 84Rest of North America PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 85Rest of North America PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 86Rest of North America PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 87Rest of North America PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 88Rest of North America PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 89Europe PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 90Europe PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 91Europe PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 92Europe PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 93Europe Kits Market by Country, 2020 - 2023, USD Million
TABLE 94Europe Kits Market by Country, 2024 - 2031, USD Million
TABLE 95Europe Assays Market by Country, 2020 - 2023, USD Million
TABLE 96Europe Assays Market by Country, 2024 - 2031, USD Million
TABLE 97Europe PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 98Europe PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 99Europe Breast Cancer Market by Country, 2020 - 2023, USD Million
TABLE 100Europe Breast Cancer Market by Country, 2024 - 2031, USD Million
TABLE 101Europe Ovarian Cancer Market by Country, 2020 - 2023, USD Million
TABLE 102Europe Ovarian Cancer Market by Country, 2024 - 2031, USD Million
TABLE 103Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 104Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 105Europe PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 106Europe PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 107Europe BRCA 1 & 2 Testing Market by Country, 2020 - 2023, USD Million
TABLE 108Europe BRCA 1 & 2 Testing Market by Country, 2024 - 2031, USD Million
TABLE 109Europe HRD Testing Market by Country, 2020 - 2023, USD Million
TABLE 110Europe HRD Testing Market by Country, 2024 - 2031, USD Million
TABLE 111Europe HRR Testing Market by Country, 2020 - 2023, USD Million
TABLE 112Europe HRR Testing Market by Country, 2024 - 2031, USD Million
TABLE 113Europe Others Market by Country, 2020 - 2023, USD Million
TABLE 114Europe Others Market by Country, 2024 - 2031, USD Million
TABLE 115Europe PARP Inhibitor Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 116Europe PARP Inhibitor Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 117Germany PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 118Germany PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 119Germany PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 120Germany PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 121Germany PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 122Germany PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 123Germany PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 124Germany PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 125UK PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 126UK PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 127UK PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 128UK PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 129UK PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 130UK PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 131UK PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 132UK PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 133France PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 134France PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 135France PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 136France PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 137France PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 138France PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 139France PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 140France PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 141Russia PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 142Russia PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 143Russia PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 144Russia PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 145Russia PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 146Russia PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 147Russia PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 148Russia PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 149Spain PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 150Spain PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 151Spain PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 152Spain PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 153Spain PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 154Spain PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 155Spain PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 156Spain PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 157Italy PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 158Italy PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 159Italy PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 160Italy PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 161Italy PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 162Italy PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 163Italy PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 164Italy PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 165Rest of Europe PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 166Rest of Europe PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 167Rest of Europe PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 168Rest of Europe PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 169Rest of Europe PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 170Rest of Europe PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 171Rest of Europe PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 172Rest of Europe PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 173Asia Pacific PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 174Asia Pacific PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 175Asia Pacific PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 176Asia Pacific PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 177Asia Pacific Kits Market by Country, 2020 - 2023, USD Million
TABLE 178Asia Pacific Kits Market by Country, 2024 - 2031, USD Million
TABLE 179Asia Pacific Assays Market by Country, 2020 - 2023, USD Million
TABLE 180Asia Pacific Assays Market by Country, 2024 - 2031, USD Million
TABLE 181Asia Pacific PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 182Asia Pacific PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 183Asia Pacific Breast Cancer Market by Country, 2020 - 2023, USD Million
TABLE 184Asia Pacific Breast Cancer Market by Country, 2024 - 2031, USD Million
TABLE 185Asia Pacific Ovarian Cancer Market by Country, 2020 - 2023, USD Million
TABLE 186Asia Pacific Ovarian Cancer Market by Country, 2024 - 2031, USD Million
TABLE 187Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 188Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 189Asia Pacific PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 190Asia Pacific PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 191Asia Pacific BRCA 1 & 2 Testing Market by Country, 2020 - 2023, USD Million
TABLE 192Asia Pacific BRCA 1 & 2 Testing Market by Country, 2024 - 2031, USD Million
TABLE 193Asia Pacific HRD Testing Market by Country, 2020 - 2023, USD Million
TABLE 194Asia Pacific HRD Testing Market by Country, 2024 - 2031, USD Million
TABLE 195Asia Pacific HRR Testing Market by Country, 2020 - 2023, USD Million
TABLE 196Asia Pacific HRR Testing Market by Country, 2024 - 2031, USD Million
TABLE 197Asia Pacific Others Market by Country, 2020 - 2023, USD Million
TABLE 198Asia Pacific Others Market by Country, 2024 - 2031, USD Million
TABLE 199Asia Pacific PARP Inhibitor Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 200Asia Pacific PARP Inhibitor Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 201China PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 202China PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 203China PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 204China PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 205China PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 206China PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 207China PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 208China PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 209Japan PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 210Japan PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 211Japan PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 212Japan PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 213Japan PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 214Japan PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 215Japan PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 216Japan PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 217India PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 218India PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 219India PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 220India PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 221India PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 222India PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 223India PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 224India PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 225South Korea PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 226South Korea PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 227South Korea PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 228South Korea PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 229South Korea PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 230South Korea PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 231South Korea PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 232South Korea PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 233Singapore PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 234Singapore PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 235Singapore PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 236Singapore PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 237Singapore PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 238Singapore PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 239Singapore PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 240Singapore PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 241Malaysia PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 242Malaysia PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 243Malaysia PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 244Malaysia PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 245Malaysia PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 246Malaysia PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 247Malaysia PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 248Malaysia PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 249Rest of Asia Pacific PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 250Rest of Asia Pacific PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 251Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 252Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 253Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 254Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 255Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 256Rest of Asia Pacific PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 257LAMEA PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 258LAMEA PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 259LAMEA PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 260LAMEA PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 261LAMEA Kits Market by Country, 2020 - 2023, USD Million
TABLE 262LAMEA Kits Market by Country, 2024 - 2031, USD Million
TABLE 263LAMEA Assays Market by Country, 2020 - 2023, USD Million
TABLE 264LAMEA Assays Market by Country, 2024 - 2031, USD Million
TABLE 265LAMEA PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 266LAMEA PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 267LAMEA Breast Cancer Market by Country, 2020 - 2023, USD Million
TABLE 268LAMEA Breast Cancer Market by Country, 2024 - 2031, USD Million
TABLE 269LAMEA Ovarian Cancer Market by Country, 2020 - 2023, USD Million
TABLE 270LAMEA Ovarian Cancer Market by Country, 2024 - 2031, USD Million
TABLE 271LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 272LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 273LAMEA PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 274LAMEA PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 275LAMEA BRCA 1 & 2 Testing Market by Country, 2020 - 2023, USD Million
TABLE 276LAMEA BRCA 1 & 2 Testing Market by Country, 2024 - 2031, USD Million
TABLE 277LAMEA HRD Testing Market by Country, 2020 - 2023, USD Million
TABLE 278LAMEA HRD Testing Market by Country, 2024 - 2031, USD Million
TABLE 279LAMEA HRR Testing Market by Country, 2020 - 2023, USD Million
TABLE 280LAMEA HRR Testing Market by Country, 2024 - 2031, USD Million
TABLE 281LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 282LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 283LAMEA PARP Inhibitor Biomarkers Market by Country, 2020 - 2023, USD Million
TABLE 284LAMEA PARP Inhibitor Biomarkers Market by Country, 2024 - 2031, USD Million
TABLE 285Brazil PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 286Brazil PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 287Brazil PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 288Brazil PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 289Brazil PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 290Brazil PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 291Brazil PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 292Brazil PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 293Argentina PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 294Argentina PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 295Argentina PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 296Argentina PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 297Argentina PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 298Argentina PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 299Argentina PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 300Argentina PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 301UAE PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 302UAE PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 303UAE PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 304UAE PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 305UAE PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 306UAE PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 307UAE PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 308UAE PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 309Saudi Arabia PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 310Saudi Arabia PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 311Saudi Arabia PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 312Saudi Arabia PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 313Saudi Arabia PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 314Saudi Arabia PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 315Saudi Arabia PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 316Saudi Arabia PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 317South Africa PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 318South Africa PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 319South Africa PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 320South Africa PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 321South Africa PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 322South Africa PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 323South Africa PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 324South Africa PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 325Nigeria PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 326Nigeria PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 327Nigeria PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 328Nigeria PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 329Nigeria PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 330Nigeria PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 331Nigeria PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 332Nigeria PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 333Rest of LAMEA PARP Inhibitor Biomarkers Market, 2020 - 2023, USD Million
TABLE 334Rest of LAMEA PARP Inhibitor Biomarkers Market, 2024 - 2031, USD Million
TABLE 335Rest of LAMEA PARP Inhibitor Biomarkers Market by Product, 2020 - 2023, USD Million
TABLE 336Rest of LAMEA PARP Inhibitor Biomarkers Market by Product, 2024 - 2031, USD Million
TABLE 337Rest of LAMEA PARP Inhibitor Biomarkers Market by Application, 2020 - 2023, USD Million
TABLE 338Rest of LAMEA PARP Inhibitor Biomarkers Market by Application, 2024 - 2031, USD Million
TABLE 339Rest of LAMEA PARP Inhibitor Biomarkers Market by Services, 2020 - 2023, USD Million
TABLE 340Rest of LAMEA PARP Inhibitor Biomarkers Market by Services, 2024 - 2031, USD Million
TABLE 341Key Information - Myriad Genetics, Inc.
TABLE 342Key Information - Thermo Fisher Scientific, Inc.
TABLE 343key information - Illumina, Inc.
TABLE 344Key Information - neogenomics, inc.
TABLE 345Key Information - Qiagen N.V.
TABLE 346key Information - Agilent Technologies, Inc.
TABLE 347key Information - Merck KGaA
TABLE 348Key Information - Bayer AG
TABLE 349Key Information - AstraZeneca PLC
TABLE 350Key Information - GlaxoSmithKline PLC

Global PARP Inhibitor Biomarkers Market Size, Share & Trends Analysis Report By Product (Kits, and Assays), By Application, By Services (BRCA 1 & 2 Testing, HRD Testing, HRR Testing, and Others), By Regional Outlook and Forecast, 2024 - 2031

Description

Table of Contents